Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

6

Number of overlapping holdings

21.4%

% of PBE's 28 holdings also in PTH

17.1%

% of PTH's 35 holdings also in PBE

Overlap by Weight
Sector Drift (PBE minus PTH)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in PBE
Weight
in PTH
Overlap
TG THERAPEUTICS INC 4.0% 3.7% 3.7%
EXELIXIS INC 3.0% 4.0% 3.0%
PROTAGONIST THERAPEUTICS, INC. 4.1% 2.9% 2.9%
CATALYST PHARMACEUTICAL PART 3.3% 2.6% 2.6%
PTC THERAPEUTICS INC 2.9% 2.6% 2.6%

Position Highlights (Non-Overlapping Exposures)
PBE Overweight Relative to PTH
NATERA INC 5.4%
GILEAD SCIENCES INC 5.3%
AMGEN INC 5.0%
NEUROCRINE BIOSCIENCES INC 4.9%
BIOGEN IDEC INC 4.7%
UNITED THERAPEUTICS CORP 4.5%
REGENERON PHARMACEUTICALS 4.4%
ILLUMINA INC 4.2%
ROYALTY PHARMA PLC CLASS A 3.0%
COLLEGIUM PHARMACEUTICAL, INC. 2.9%
PBE Underweight Relative to PTH
CENCORA INC -4.5%
ELI LILLY & CO -4.3%
ALIGNMENT HEALTHCARE, INC. -3.9%
BOSTON SCIENTIFIC CORP -3.6%
GUARDANT HEALTH, INC. -3.5%
KRYSTAL BIOTECH, INC. -3.5%
INSMED INC -3.4%
AXSOME THERAPEUTICS, INC. -3.3%
BRIDGEBIO PHARMA, INC. -3.3%
MADRIGAL PHARMACEUTICALS, INC. -3.2%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY